Prelude Therapeutics Incorporated (PRLD)
NASDAQ·Healthcare·Biotechnology
$4.56
+3.64%
Mkt Cap $252.78M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (6 analysts)
$8.00
Range $8.00 – $8.00
Implied Upside
+75.4%
Consensus $8.00 vs current $4.56
NASDAQ·Healthcare·Biotechnology
$4.56
+3.64%
Mkt Cap $252.78M
Buy
1
Hold
0
Sell
0
Price Target (6 analysts)
$8.00
Range $8.00 – $8.00
+75.4%
Consensus $8.00 vs current $4.56